» Articles » PMID: 2553304

Partial Purification and Characterization of Human Hepatoma-derived Growth Factor

Overview
Journal Clin Chim Acta
Specialty Biochemistry
Date 1989 Aug 31
PMID 2553304
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

A human hepatoma cell line, HuH-7, which was established from a hepatoma tissue removed at surgical operation from an adult Japanese male, grows autonomously in a serum-free chemically defined medium. A human hepatoma-derived growth factor with potent growth-promoting activity, was partially purified from the conditioned medium of HuH-7 cells, using ion-exchange, heparin affinity chromatography and gel filtration. The partially purified growth factor (HuHGF) is acid- and heat-labile, and sensitive to reduction and trypsin digestion. HuHGF, which is of relatively high molecular weight (about 64 kDa) examined by gel filtration, stimulates not only the DNA synthesis of Swiss mouse 3T3 fibroblasts, but also the growth of HuH-7 cells in serum-free chemically defined medium, suggesting that it is produced by and acts on HuH-7 cells as an autocrine growth factor. This putative growth factor may play an important role in the autonomous growth of hepatoma and may lead to useful diagnostic or therapeutic approaches to human hepatoma.

Citing Articles

FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review).

Solek J, Braun M, Sadej R, Romanska H Int J Oncol. 2024; 65(4).

PMID: 39219285 PMC: 11374155. DOI: 10.3892/ijo.2024.5682.


HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer.

Han S, Tian Z, Tian H, Han H, Zhao J, Jiao Y Cell Death Discov. 2023; 9(1):181.

PMID: 37301856 PMC: 10257651. DOI: 10.1038/s41420-023-01476-0.


NAP1L1 promotes the growth of colon cancer by activating HDGF/DDX5.

Liang X, Tang Z, Zhang Y, Sun Y, Wang J Acta Biochim Biophys Sin (Shanghai). 2022; 54(9):1234-1243.

PMID: 36148951 PMC: 9828316. DOI: 10.3724/abbs.2022124.


NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer.

Zhu X, Xie Y, Huang W, Chen Z, Guo S BMC Cancer. 2022; 22(1):339.

PMID: 35351053 PMC: 8962469. DOI: 10.1186/s12885-022-09356-z.


NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.

Liu S, Zhang Y, Cui S, Song D, Li B, Chen Q Cancer Cell Int. 2021; 21(1):605.

PMID: 34774047 PMC: 8590370. DOI: 10.1186/s12935-021-02301-3.